| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |